Erasca Inc (ERAS)
2.21
+0.07
(+3.27%)
USD |
NASDAQ |
May 06, 16:00
2.21
0.00 (0.00%)
After-Hours: 20:00
Erasca 1 Year Total Returns (Daily): -23.57% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -23.57% |
May 02, 2024 | -20.96% |
May 01, 2024 | -25.89% |
April 30, 2024 | -27.17% |
April 29, 2024 | -26.09% |
April 26, 2024 | -26.46% |
April 25, 2024 | -27.69% |
April 24, 2024 | -30.37% |
April 23, 2024 | -31.07% |
April 22, 2024 | -33.93% |
April 19, 2024 | -37.08% |
April 18, 2024 | -40.23% |
April 17, 2024 | -40.65% |
April 16, 2024 | -33.90% |
April 15, 2024 | -31.51% |
April 12, 2024 | -25.96% |
April 11, 2024 | -19.93% |
April 10, 2024 | -18.83% |
April 09, 2024 | -24.67% |
April 08, 2024 | -25.33% |
April 05, 2024 | -28.81% |
April 04, 2024 | -28.42% |
April 03, 2024 | -31.11% |
April 02, 2024 | -28.57% |
April 01, 2024 | -28.24% |
Date | Value |
---|---|
March 28, 2024 | -24.82% |
March 27, 2024 | -26.16% |
March 26, 2024 | -30.04% |
March 25, 2024 | -26.86% |
March 22, 2024 | -26.12% |
March 21, 2024 | -31.31% |
March 20, 2024 | -30.92% |
March 19, 2024 | -33.01% |
March 18, 2024 | -33.01% |
March 15, 2024 | -32.92% |
March 14, 2024 | -36.39% |
March 13, 2024 | -30.84% |
March 12, 2024 | -29.84% |
March 11, 2024 | -26.56% |
March 08, 2024 | -31.94% |
March 07, 2024 | -37.50% |
March 06, 2024 | -35.65% |
March 05, 2024 | -35.14% |
March 04, 2024 | -32.86% |
March 01, 2024 | -27.14% |
February 29, 2024 | -33.89% |
February 28, 2024 | -34.72% |
February 27, 2024 | -31.67% |
February 26, 2024 | -33.15% |
February 23, 2024 | -35.01% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-77.92%
Minimum
Dec 04 2023
-18.83%
Maximum
Apr 10 2024
-58.74%
Average
-62.06%
Median
Sep 23 2022
1 Year Total Returns (Daily) Benchmarks
Exelixis Inc | 14.00% |
Geron Corp | 47.19% |
Verastem Inc | 106.4% |
Karyopharm Therapeutics Inc | -69.13% |
Kura Oncology Inc | 93.53% |